Learning objectives Setelah mengikuti kuliah ini, mahasiswa smt 5 FK UNAIR mampu menjelaskan : • Mekanisme dasar neurotoksisitas • Obat yang dapat menyebabkan efek gangguan keseimbangan • Mekanisme toksisitas obat/senyawa terhadap sistem keseimbangan • Obat yang digunakan untuk terapi gangguan keseimbangan Outlines • Basic of neurotoxicity • Mechanism of neurotoxicity • Drug/substance which may cause equillibrium disorder • Mechanism of vestibulotoxic drugs • Mechanism of drug induced cerebellar disorder • Mechanism of drug induced sensory ataxia • Drug treatment for equilibrium disorder Anatomical & physiological basis of neurotoxicity • The privileged status of nervous system → protected with blood brain barrier • High energy requirements • Spatial extensions as long cellular processes • The transmission of information across synapse • The maintenance of an environment rich in lipids Comparison between systemic and brain capillaries Patterns of neurotoxic injuries Mechanisms of neurotoxicity Targets of neurotoxic agents: • Neuron • Axon • Myelinating cell • Neurotransmitter system Neuronopathies • Injury or death of neurons • Irreversible • Include degeneration of all of its cytoplasmic extensions, dendrites, axons, myelin • Toxic agents tend to be diffuse in their action → often diffuse encephalopathy w/ global dysfunction Axonopathies • Axon degenerates • Cell body intact • Effect of toxicants – chemical transection • Peripheral axon can regenerate whereas central axon cannot • Sensations and motor strength are first impaired in the feet & hands → “ glove & stocking” neuropathy Myelinopathies • Absence of myelin – slowing of conduction & aberrant conduction of impulses • Exposure to toxicants : separation of the myelin lamellae (intramyelinic edema) selective loss of myelin (demyelination) • Remyelination : CNS (limited) Neurotransmission-associated neurotoxicity Mechanisms • Interrupt transmission of impulses • Block or accentuate transsynaptic communication • Block the reuptake of neurotransmitter • Interfere with second- messenger systems Drug/substance induced equilibrium disorder Toxic vestibulopathies Substances Mechanisms Manifestations Alcohol Differential distribution between Acute positional vertigo cupula and endolymph Aminoglycosides Destroying sensory hair cells Vertigo; nausea vomiting; Streptomycin gait ataxia; nystagmus Gentamycin Tobramycin Salicylates Cochlear and vestibular end Vertigo, tinnitus, organ damage sensoryneural hearing loss Quinine Impairment of N. VIII; Alteration Cinchonism: vertigo, of outer hari cells; decrease tinitus, sensoryneural blood flow hearing loss Cisplatin ATPase inhibition & increased Tinnitus, vestibular oxidative stress in labyrinth dysfunction Drug/substance induced cerebellar disorder Acute Chronic Due to acute intoxication of: • Alcoholic cerebellar • Ethanol degeneration • Sedative hypnotics • Toxin induced cerebellar • anti convulsants degeneration • hallucinogens - Phenytoin; Lithium; Amiodarone; Fluorouracil; Cytarabine; Toluene; Lead; Mercury; Thallium Drug/substance induced cerebellar disorder Substances Mechanisms Manifestations Phenytoin Degeneration of Nystagmus, ataxia, Purkinje cells dizziness Alcohol -Pirkinje cells loss in -ataxia; nystagmus; superior vermis dysarthria -Thiamine deficiency -Wernicke encephalopathy Cytarabine -Purkinje cells loss -ataxia; dysarthria; in the depths of nystagmus cortical sulci Drug/substance induced sensory ataxia • Sensory neuronopathy- targets dorsal root ganglia Ex: Doxorubicin (lack data in human); High dose of Pyridoxine • Sensory neuropathy- targets peripheral sensory nerves Ex: Isoniazid, Platinum analogs, Podopyllin, Taxol • Myelopathy – targets posterior columns of spinal cord • Combined lesions: Nitrous oxide, Vit B12 deficiency, Vit E deficiency Vestibular vertigo disorder nystagmus
Equilibrium disorder symptoms
Cerebellar or sensory ataxia
Soto, E., Vega, R., & Seseña, E. (2013). Neuropharmacological basis of vestibular system disorder treatment. Journal of Vestibular Research, 23(3), 119-137. Drug treatment for vestibular disorder-based on molecular target Antihistamin Anticholiner Calcium GABA e gic antagonist
Dyphenhyra Atropine Flunarizine Baclofen mine Gabapentin Dimenhydrin ate Meclizine Cyclizine Mecha improves the Reduced -antihistaminic inhibitory input on nism labyrinthine activation of action the microcirculati vestibular -affect the input and vestibular nuclei on by acting neurons output on the of information of the precapillary vestibular nuclei sphincters of -blocker of the the stria pressure sensitive vascularis potassium channels Principles of pharmacotherapy in vestibular disorders • acute vestibular symptoms • specific treatment -for 1. Correct example, Meniere’s diagnosis disease, migraine or 4Ds 2. Correct drug epilepsy 3. Appropriate • non-specific but empirical dosage treatment of a chronic 4. Sufficient vestibular disorder —for duration example, central vestibular symptoms. Refferences Aminoff MJ, Greenberg DA, Simon RP. 2015. Clinical Neurology 9th ed. The McGraw-Hill companies Brunton L, Chabner B, Knollman B, 2011. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, 12thed. USA: The Mc Graw- Hill Companies, Inc. Katzung BG, Trevor AJ, 2015. Basic and clinical pharmacology, 13thed. USA: The McGraw-Hill Companies, Inc. Klaassen, C. D. (2008). Casarett & Doull's toxicology(7th ed.). McGraw-Hill Medical Luxxon LM. 2004. Neurol Neurosurg Psychiatry;75(Suppl IV):iv45– iv52. doi: 10.1136/jnnp.2004.055285 Soto, E., Vega, R., & Seseña, E. (2013). Neuropharmacological basis of vestibular system disorder treatment. Journal of Vestibular Research, 23(3), 119-137 Yacovino DA, Luis L. 2014. Pharmacologic treatment of vestibular disorder. Vestibular disorder association. Vestibular.org